OYST
|
Oyster Point Pharma, Inc.
|
0.01%
|
US
|
NASDAQ
|
OVID
|
Ovid Therapeutics Inc.
|
0.01%
|
US
|
NASDAQ
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
NXTC
|
NextCure, Inc.
|
0.01%
|
US
|
NASDAQ
|
MREO
|
Mereo BioPharma Group plc
|
0.01%
|
US
|
NASDAQ
|
MGTA
|
Magenta Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
LPTX
|
LEAP THERAPEUTICS, INC.
|
0.01%
|
US
|
NASDAQ
|
JNCE
|
Jounce Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
IMUX
|
Immunic, Inc.
|
0.01%
|
US
|
NASDAQ
|
IMRX
|
Immuneering Corporation
|
0.01%
|
US
|
NASDAQ
|
IKNA
|
Ikena Oncology, Inc.
|
0.01%
|
US
|
NASDAQ
|
HROW
|
Harrow Health, Inc.
|
0.01%
|
US
|
NASDAQ
|
HOWL
|
Werewolf Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
HBIO
|
Harvard Bioscience, Inc.
|
0.01%
|
US
|
NASDAQ
|
HARP
|
Harpoon Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
GRTS
|
Gritstone Oncology, Inc.
|
0.01%
|
US
|
NASDAQ
|
GRPH
|
Graphite Bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
GMDA
|
Gamida Cell Ltd.
|
0.01%
|
US
|
NASDAQ
|
FREQ
|
Frequency Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
FIXX
|
Homology Medicines, Inc.
|
0.01%
|
US
|
NASDAQ
|